Purine and pyrimidine receptors

Cellular and Molecular Life Sciences

Volumn 64, Issue 12, 2007, Pages 1471-1483

  Burnstock, G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cloned receptors; G protein coupled receptors; Gene regulation; Heteromultimers; Ion channel receptors; P1 receptor; P2X receptor; P2Y receptor

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; G PROTEIN COUPLED RECEPTOR; LIGAND; PROTEIN SUBUNIT; PURINE P2X RECEPTOR; PURINE P2X1 RECEPTOR; PURINE P2X2 RECEPTOR; PURINE P2X3 RECEPTOR; PURINE P2X4 RECEPTOR; PURINE P2X5 RECEPTOR; PURINE P2X6 RECEPTOR; PURINE P2X7 RECEPTOR; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y11 RECEPTOR; PURINE P2Y12 RECEPTOR; PURINE P2Y13 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y4 RECEPTOR; PURINE P2Y6 RECEPTOR; PURINE RECEPTOR; PYRIMIDINE;

CHANNEL GATING; DIMERIZATION; GENE ACTIVATION; GENETIC REGULATION; MOLECULAR CLONING; MOLECULAR INTERACTION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ADENOSINE TRIPHOSPHATE; ANIMALS; DIMERIZATION; GENE EXPRESSION REGULATION; HUMANS; PURINES; PYRIMIDINES; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2; TRANS-ACTIVATION (GENETICS);

EID: 34250719722     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-6497-0     Document Type: Review

References (125)

1. Drury, A. N. and Szent-Györgyi, A. (1929) The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J. Physiol. (Lond) 68, 213-237.
2. Burnstock, G. (1972) Purinergic nerves. Pharmacol. Rev. 24, 509-581.
3. Burnstock, G. (1976) Purinergic receptors. J. Theor. Biol. 62, 491-503.
4. Burnstock, G. (1978) A basis for distinguishing two types of purinergic receptor. In: Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach, pp. 107-118, Straub, R. W. and Bolis, L. (eds.), Raven Press, New York.
5. Van Calker, D., Müller, M. and Hamprecht, B. (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33, 999-1005.
6. Londos, C., Cooper, D. M. and Wolff, J. (1980) Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. USA 77, 2551-2554.
7. Burnstock, G. and Kennedy, C. (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen. Pharmacol. 16, 433-440.
8. Lustig, K. D., Shiau, A. K., Brake, A. J. and Julius, D. (1993) Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. USA 90, 5113-5117.
9. Webb, T. E., Simon, J., Krishek, B. J., Bateson, A. N., Smart, T. G., King, B. F. Burnstock, G. and Barnard, E. A. (1993). Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 324, 219-225.
10. Brake, A. J., Wagenbach, M. J. and Julius, D. (1994) New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371, 519-523.
11. 2X receptor for extra-cellular ATP. Nature 371, 516-519.
12. 2Y purinoceptors? Pharmacol. Ther. 64, 445-475.
13. Ralevic, V. and Burnstock, G. (1998) Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-492.
14. North, R. A. (2002) Molecular physiology of P2X receptors. Physiol. Rev. 82, 1013-1067.
15. Abbracchio, M. P., Burnstock, G., Boeynaems, J.-M., Barnard, E. A., Boyer, J. L., Kennedy, C., Knight, G. E., Fumagalli, M., Gachet, C., Jacobson, K. A. et al. (2006) International Union of Pharmacology. Update and subclassification of the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 58, 281-341.
16. Burnstock, G. and Knight, G. E. (2004) Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 240, 31-304.
17. Burnstock, G. (2006) Pathophysiology and therapeutic potential of purinergic signalling. Pharmacol. Rev. 58, 58-86.
18. Abbracchio, M. P. and Burnstock, G. (1998) Purinergic signalling: pathophysiological roles. Jpn. J. Pharmacol. 78, 113-145.
19. Burnstock, G. (2002) Purinergic signalling and vascular cell proliferation and death. Arteriosclerosis Thromb. Vasc. Biol. 22, 364-373.
20. Libert, F., Parmentier, M., Lefort, A., Dinsart, C., Van, S. J., Maenhaut, C., Simons, M. J., Dumont, J. E. and Vassart, G. (1989) Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science 244, 569-572.
21. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA 89, 7432-7436.
22. Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K. N. and Linden, J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527-552.
23. Olah, M. E. and Stiles, G. L. (2000) The role of receptor structure in determining adenosine receptor activity. Pharmacol. Ther. 85, 55-75.
24. Cobb, B. R. and Clancy, J. P. (2003) Molecular and cell biology of adenosine receptors. Curr. Top. Membr. 54, 151-181.
25. Yaar, R., Jones, M. R., Chen, J. F. and Ravid, K. (2005) Animal models for the study of adenosine receptor function. J. Cell. Physiol. 202, 9-20.
26. 6 cells. J. Membr. Biol. 178, 103-113.
27. Ledent, C., Vaugeois, J. M., Schiffmann, S. N., Pedrazzini, T., El Yacoubi, M., Vanderhaeghen, J. J., Costentin, J., Heath, J. K., Vassart, G. and Parmentier, M. (1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388, 674-678.
28. Sun, D., Samuelson, L. C., Yang, T., Huang, Y., Paliege, A., Saunders, T., Briggs, J. and Schnermann, J. (2001) Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc. Natl. Acad. Sci. USA 98, 9983-9988.
29. Lankford, A. R., Yang, J. N., Rose'Meyer, R., French, B. A., Matherne, G. P., Fredholm, B. B. and Yang, Z. (2006) Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning. Am. J. Physiol. Circ. Physiol. 290, H1469-H1473.
30. Stojilkovic, S., Tomic, M., He, M. L., Yan, Z., Koshimizu, T.-A. and Zemkova, H. (2005) Molecular dissection of purinergic P2X receptor channels. Ann. N.Y. Acad. Sci. 1048, 116-130.
31. Egan, T. M., Samways, D. S., and Li, Z. (2006) Biophysics of P2X receptors. Pflüger's Arch. 452, 501-512.
32. Roberts, J. A., Vial, C., Digby, H. R., Agboh, K. C., Wen, H., Atterbury-Thomas, A. and Evans, R. J. (2006) Molecular properties of P2X receptors. Pflüger's Arch. 452, 486-500.
33. 3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J. 17, 3016-3028.
34. Gever, J., Cockayne, D. A., Dillon, M. P., Burnstock, G. and Ford, A. P. D. W. (2006) Pharmacology of P2X channels. Pflüger's Arch. 452, 513-537.
35. 4a receptors. Brain Res. Mol. Brain Res. 64, 246-254.
36. Burnstock, G. (2007) Physiology and pathophysiology of purinergic transmission. Physiol. Rev. 87, 659-797.
37. 2 receptors. Mol. Pharmacol. 56, 1171-1181.
38. 1/2 receptors show a novel sensitivity to extracellular pH. J. Pharmacol. Exp. Ther. 300, 673-680.
39. 1+2 receptor subtypes. J. Mol. Biol. 342, 333-343.
40. 1 receptors revealed using knockout mice. Mol. Pharmacol. 65, 139-148.
41. Chen, C. C., Akopian, A. N., Sivilotti, L., Colquhoun, D., Burnstock, G. and Wood, J. N. (1995) A P2X purinoceptor expressed by a subset of sensory neurons. Nature 377, 428-431.
42. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 377, 432-435.
43. 3 purinoceptor. Brain Res. Mol. Brain Res. 47, 59-66.
44. 3 subunit. FEBS Lett. 475, 287-290.
45. Burnstock, G. (2003) Introduction: ATP and its metabolites as potent extracellular agonists. In: Current Topics in Membranes, vol. 54, Purinergic Receptors and Signalling, pp. 1-27, Schwiebert, E. M. (ed.), Academic Press, San Diego.
46. Torres, G. E., Egan, T. M. and Voigt, M. M. (1999) Heterooligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J. Biol. Chem. 274, 6653-6659.
47. 2/3 receptors by 2′,3′-O-(2,4,6- trinitrophenyl) adenosine 5′-triphosphate (TNP-ATP). Mol. Pharmacol. 58, 1502-1510.
48. 2 receptor subunits in varying amounts generates heterogenous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neurons. J. Pharmacol. Exp. Ther. 296, 1043-1050.
49. 2/3 heteromeric receptors. Br. J. Pharmacol. 135, 1524-1530.
50. 2/3 receptors. Br. J. Pharmacol. 140, 1027-1034.
51. 2/3 receptors and between two P2X receptors in rat sensory neurones. Br. J. Pharmacol. 130, 1378-1384.
52. Bo, X., Zhang, Y., Nassar, M., Burnstock, G. and Schoepfer, R. (1995) A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett. 375, 129-133.
53. Buell, G., Collo, G. and Rassendren, F. (1996) P2X receptors: an emerging channel family. Eur. J. Neurosci. 8, 2221-2228.
54. 4: an ATP-activated ionotropic receptor cloned from rat brain. Proc. Natl. Acad. Sci. USA 93, 3684-3688.
55. 4 subunits. J. Neurochem. 92, 925-933.
56. Garcia-Guzman, M., Soto, F., Laube, B. and St hmer, W. (1996) Molecular cloning and functional expression of a novel rat heart P2X purinoceptor. FEBS Lett. 388, 123-127.
57. Bo, X., Schoepfer, R. and Burnstock, G. (2000) Molecular cloning and characterization of a novel ATP P2X receptor subtype from embryonic chick skeletal muscle. J. Biol. Chem. 275, 14401-14407.
58. 5 receptor subunits reveals a novel ATP-gated ion channel. Mol. Pharmacol. 54, 989-993.
59. 5 subunits. J. Biol. Chem. 274, 15415-15419.
60. 1/5 receptors expressed in HEK cells and excitatory junction potentials in guinea-pig submucosal arterioles. J. Auton. Nerv. Syst. 81, 249-263.
61. Soto, F., Garcia-Guzman, M., Karschin, C. and Stuhmer, W. (1996) Cloning and tissue distribution of a novel P2X receptor from rat brain. Biochem. Biophys. Res. Commun. 223, 456-460.
62. 6 subunits in Xenopus oocytes. J. Neurosci. 20, 4871-4877.
63. 4 receptor channels. J. Neurosci. 19, 7289-7299.
64. 2X receptor (P2X7). Science 272, 735-738.
65. 7. Cloning and expression of a human cDNA. J. Biol. Chem. 272, 5482-5486.
66. 7 receptor. FEBS Lett. 439, 26-30.
67. Hollopeter, G., Jantzen, H.-M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R.-B., Nurden, P., Nurden, A., Julius, D. and Conley, P. B. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409, 202-207.
68. Chambers, J. K., Macdonald, L. E., Sarau, H. M., Ames, R. S., Freeman, K., Foley, J. J., Zhu, Y., McLaughlin, M. M., Murdock, P., McMillan, L. et al. (2000) A G protein-coupled receptor for UDP-glucose. J. Biol. Chem. 275, 10767-10771.
69. i. J. Biol. Chem. 276, 41479-41485.
70. 14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol. Sci. 24, 52-55.
71. 6 receptor. Mol. Pharmacol 54, 541-546.
72. 4 that mediates chemotaxis. Nature 387, 620-624.
73. Bogdanov, Y. D., Dale, L., King, B. F., Whittock, N. and Burnstock, G. (1997) Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos. J. Biol. Chem. 272, 12583-12590.
74. Noguchi, K., Ishii, S. and Shimizu, T. (2003) Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 278, 25600-25606.
75. 15, for AMP and adenosine. J. Biol. Chem. 279, 19790-19799.
76. 15 receptor is not a genuine P2Y receptor. Trends Pharmacol. Sci. 26, 8-9.
77. 1 receptor. Mol. Pharmacol. 52, 499-507.
78. Hille, B. (1994) Modulation of ion-channel function by G-protein-coupled receptors. Trends Neurosci. 17, 531-536.
79. Dolphin, A. C. (2003) G protein modulation of voltage-gated calcium channels. Pharmacol. Rev. 55, 607-627.
80. Zhang, J. M., Wang, H. K., Ye, C. Q., Ge, W., Chen, Y., Jiang, Z. L., Wu, C. P., Poo, M. M. and Duan, S. (2003) ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 40, 971-982.
81. Bowser, D. N. and Khakh, B. S. (2004) ATP excites interneurons and astrocytes to increase synaptic inhibition in neuronal networks. J. Neurosci. 24, 8606-8620.
82. Vassort, G. (2001) Adenosine 5′-triphosphate: a P2-purinergic agonist in the myocardium. Physiol. Rev. 81, 767-806.
83. Selyanko, A. A., Hadley, J. K. and Brown, D. A. (2001) Properties of single M-type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells. J. Physiol. 534, 15-24.
84. 1 receptor. Mol. Pharmacol. 65, 426-436.
85. 13 receptors by conformational constraint of an ADP analog. J. Pharmacol. Exp. Ther. 311, 1038-1043.
86. 1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J. Med. Chem. 41, 1456-1466.
87. 1 receptor in surface expression and activation processes. J. Biol. Chem. 274, 14639-14647.
88. 1 purinoceptor. Gene 171, 295-297.
89. 1 purinergic receptor in Alzheimer's disease. Neuroreport 11, 3799-3803.
90. 1-deficient mice. Nat. Med. 5, 1199-1202.
91. 1 receptor-null mice. J. Clin. Invest. 104, 1731-1737.
92. 1 receptor induces platelet hyper-reactivity in transgenic mice. J. Thromb. Haemost. 1, 155-163.
93. 2 receptor in coronary artery smooth muscle cells. Mol. Pharmacol. 66, 1265-1274.
94. Weick, M., Cherkas, P. S., Hartig, W., Pannicke, T., Uckermann, O., Bringmann, A., Tal, M., Reichenbach, A. and Hanani, M. (2003) P2 receptors in satellite glial cells in trigeminal ganglia of mice. Neuroscience 120, 969-977.
95. Xu, J., Chalimoniuk, M., Shu, Y., Simonyi, A., Sun, A. Y., Gonzalez, F. A., Weisman, G. A., Wood, W. G. and Sun, G. Y. (2003) Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukot. Essent. Fatty Acids 69, 437-448.
96. 2 receptors and increased mitogenic responses to UTP and ATP. Arterioscler. Thromb. Vasc. Biol. 20, 2064-2069.
97. 2 nucleotide receptors mediate uridine 5′-triphosphate- induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 106, 2720-2726.
98. 2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease. Adv. Drug Deliv. Rev. 54, 1463-1474.
99. - transport. J. Biol. Chem. 274, 26461-26468.
100. 2 receptor in bone remodelling. J. Cell. Biochem. 86, 413-419.
101. Brown, D. A., Filippov, A. K. and Barnard, E. A. (2000) Inhibition of potassium and calcium currents in neurones by molecularly-defined P2Y receptors. J. Auton. Nerv. Syst. 81, 31-36.
102. 4. AfCS-Nature Molecule Pages ID A001691.
103. 4 nucleotide receptor. Special Report. Br. J. Pharmacol. 124, 428-430.
104. 4-null mice. Mol. Pharmacol. 63, 777-783.
105. Lazarowski, E. R., Rochelle, L. G., O'Neal, W. K., Ribeiro, C. M., Grubb, B. R., Zhang, V., Harden, T. K. and Boucher, R. C. (2001) Cloning and functional characterization of two murine uridine nucleotide receptors reveal a potential target for correcting ion transport deficiency in cystic fibrosis gallbladder. J. Pharmacol. Exp. Ther. 297, 43-49.
106. Pendergast, W., Yerxa, B. R., Douglass, J. G., III, Shaver, S. R., Dougherty, R. W., Redick, C. C., Sims, I. F. and Rideout, J. L. (2001) Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5′-polyphosphates. Bioorg. Med. Chem. Lett. 11, 157-160.
107. 11 receptor. Br. J. Pharmacol. 128, 1199-1206.
108. 11 and SSF1 genes. J. Biol. Chem. 276, 16561-16566.
109. 12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin. Thromb. Hemost. 31, 174-183.
110. Foster, C. J., Prosser, D. M., Agans, J. M., Zhai, Y., Smith, M. D., Lachowicz, J. E., Zhang, F. L., Gustafson, E., Monsma, F. J., Jr., Wiekowski, M. T. et al. (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J. Clin. Invest. 107, 1591-1598.
111. 12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J. Clin. Invest. 112, 398-406.
112. 13 receptor. Biochem. Pharmacol. 68, 113-124.
113. 14. AfCS-Nature Molecule Pages ID A002814.
114. 1 receptors in living cells: formation of ATP-sensitive adenosine receptors. Drug Dev. Res. 58, 340-349.
115. 1 receptors demonstrated by fluorescence resonance energy transfer analysis. Br. J. Pharmacol. 146, 11P.
116. Yoshioka, K., Saitoh, O. and Nakata, H. (2001) Heteromeric association creates a P2Y-like adenosine receptor. Proc. Natl. Acad. Sci. USA 98, 7617-7622.
117. 1 receptors in rat brains. FEBS Lett. 531, 299-303.
118. 1 receptor function in murine mega-karyocytes and human platelets reveals synergy with P2Y receptors. Br. J. Pharmacol. 135, 363-372.
119. 1 receptors does not involve direct channel phosphorylation. Biochem. J. 382, 101-110.
120. 2 receptors activate neuroprotective mechanisms in astrocytic cells. J. Neurochem. 91, 119-132.
121. 1 nucleotide receptor in chick muscle: its functional role in the regulation of acetylcholinesterase and acetylcholine receptor. J. Neurosci. 21, 9224-9234.
122. 2 receptor activation regulates the expression of acetylcholinesterase and acetylcholine receptor genes at vertebrate neuromuscular junctions. Mol. Pharmacol. 66, 794-806.
123. Burnstock, G. (1996) Purinoceptors: ontogeny and phylogeny. Drug Dev. Res., 39, 204-242.
124. Volont́, C., Amadio, S., D'Ambrosi, N., Colpi, M. and Burnstock, G. (2006) P2 receptor web: complexity and fine-tuning. Pharmacol. Ther. 112, 264-280.
125. Barnard, E. A., Burnstock, G. and Webb, T. E. (1994) G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. Sci. 15, 67-70.